Definitive Healthcare (NASDAQ:DH – Get Free Report) updated its second quarter earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $0.09 for the period, compared to the consensus estimate of $0.09. The company issued revenue guidance of $63.7 million, compared to the consensus revenue estimate of $62.68 million. Definitive Healthcare also updated its FY24 guidance to $0.32-0.34 EPS.
Definitive Healthcare Price Performance
Shares of NASDAQ:DH traded down $0.23 on Tuesday, reaching $5.74. The company’s stock had a trading volume of 3,706,127 shares, compared to its average volume of 710,079. Definitive Healthcare has a 52-week low of $4.38 and a 52-week high of $11.97. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.30 and a current ratio of 2.30. The company has a 50-day simple moving average of $5.55 and a 200 day simple moving average of $7.17. The company has a market cap of $676.92 million, a P/E ratio of -3.28, a PEG ratio of 4.36 and a beta of 1.30.
Definitive Healthcare (NASDAQ:DH – Get Free Report) last released its earnings results on Tuesday, May 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.04). The firm had revenue of $63.48 million during the quarter, compared to the consensus estimate of $64.00 million. Definitive Healthcare had a positive return on equity of 0.51% and a negative net margin of 78.16%. As a group, equities research analysts anticipate that Definitive Healthcare will post 0.1 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Check Out Our Latest Analysis on Definitive Healthcare
Definitive Healthcare Company Profile
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
Featured Articles
- Five stocks we like better than Definitive Healthcare
- What is the FTSE 100 index?
- AbbVie Analysts Lead the Stock Higher as Humira Worries Recede
- Compound Interest and Why It Matters When Investing
- Harley-Davidson Stock Revs Up With Billion Dollar Buyback Program
- What Are Trending Stocks? Trending Stocks Explained
- Cruise Line Stock Sinks Despite Beating EPS and Raised Guidance
Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.